Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving target assessment in biomedical research: the GOT-IT recommendations
Christoph H. Emmerich, Lorena Martinez‐Gamboa, M. Hofmann, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 1, pp. 64-81
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

Why 90% of clinical drug development fails and how to improve it?
Duxin Sun, Wei Gao, Hongxiang Hu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 3049-3062
Open Access | Times Cited: 764
TTD: Therapeutic Target Database describing target druggability information
Ying Zhou, Yintao Zhang, Donghai Zhao, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1465-D1477
Open Access | Times Cited: 159
Microfluidics for Drug Development: From Synthesis to Evaluation
Yuxiao Liu, Lingyu Sun, Hui Zhang, et al.
Chemical Reviews (2021) Vol. 121, Iss. 13, pp. 7468-7529
Closed Access | Times Cited: 131
Understanding tumour endothelial cell heterogeneity and function from single-cell omics
Qun Zeng, Mira Mousa, Aisha Shigna Nadukkandy, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 8, pp. 544-564
Closed Access | Times Cited: 72
Predictive validity in drug discovery: what it is, why it matters and how to improve it
Jack W. Scannell, Jim Bosley, John A. Hickman, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 915-931
Open Access | Times Cited: 60
Experimental models of acute kidney injury for translational research
Neil A. Hukriede, Danielle E. Soranno, Veronika Sander, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 5, pp. 277-293
Closed Access | Times Cited: 59
Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD)
Jai Woo Lee, Miguel A. Maria‐Solano, Thi Ngoc Lan Vu, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 1, pp. 241-252
Open Access | Times Cited: 46
TheMarker: a comprehensive database of therapeutic biomarkers
Yintao Zhang, Ying Zhou, Yuan Zhou, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1450-D1464
Open Access | Times Cited: 34
Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections
Ursula Theuretzbacher, Benjamin Blasco, Maëlle Duffey, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 957-975
Closed Access | Times Cited: 33
Recommendations for robust and reproducible preclinical research in personalised medicine
Vibeke Fosse, Emanuela Oldoni, Florence Biétrix, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Antimicrobial and synergistic properties of green tea catechins against microbial pathogens
Roua M. Alkufeidy, Leen Ameer Altuwijri, Noura S. Aldosari, et al.
Journal of King Saud University - Science (2024) Vol. 36, Iss. 8, pp. 103277-103277
Open Access | Times Cited: 6
Analysis of total RNA as a potential biomarker of Parkinson’s disease in silico
Snežana M Jovičić
International Journal of Immunopathology and Pharmacology (2025) Vol. 39
Open Access
Integration of Chromogenic RNAscope In Situ Hybridization for Target Validation in Drug Discovery
Rosanna Win, Wesley Minto, In Kyoung Mah, et al.
Toxicologic Pathology (2025)
Closed Access
A human metabolic map of pharmacological perturbations reveals drug modes of action
Laurentz Schuhknecht, Karin Ortmayr, Jürgen Jänes, et al.
Nature Biotechnology (2025)
Closed Access
Reproducibility, relevance and reliability as barriers to efficient and credible biomedical technology translation
Ulrich Dirnagl, Georg N. Duda, David W. Grainger, et al.
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114118-114118
Open Access | Times Cited: 31
An electroaffinity labelling platform for chemoproteomic-based target identification
Yu Kawamata, Keun Ah Ryu, Gary N. Hermann, et al.
Nature Chemistry (2023) Vol. 15, Iss. 9, pp. 1267-1275
Closed Access | Times Cited: 18
Systematic literature review reveals suboptimal use of chemical probes in cell-based biomedical research
Jayden Sterling, Jennifer R. Baker, Adam McCluskey, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood
Yi‐Jun Ge, Ya‐Nan Ou, Yue‐Ting Deng, et al.
Biological Psychiatry (2022) Vol. 93, Iss. 9, pp. 770-779
Open Access | Times Cited: 21
Antibiotics with novel mode of action as new weapons to fight antimicrobial resistance
Francesca Ruggieri, Nina Compagne, Kevin Antraygues, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115413-115413
Open Access | Times Cited: 13
Screening for in vitro systematic reviews: a comparison of screening methods and training of a machine learning classifier
Emma Wilson, Florenz A. Cruz, Duncan S. MacLean, et al.
Clinical Science (2023) Vol. 137, Iss. 2, pp. 181-193
Open Access | Times Cited: 11
Cobalt‐Catalyzed Asymmetric Hydrogenation: Substrate Specificity and Mechanistic Variability
Soumyadeep Chakrabortty, Bas de Bruin, Johannes G. de Vries
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 10
Open Access | Times Cited: 11
Antitoxin nanoparticles: design considerations, functional mechanisms, and applications in toxin neutralization
Nimeet Desai, Shreya Pande, Sagar Salave, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104060-104060
Open Access | Times Cited: 3
Medicinal polypharmacology—a scientific glossary of terminology and concepts
Sven Marcel Stefan, Muhammad Rafehi
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Mechanisms and Assessment of Genotoxicity of Metallic Engineered Nanomaterials in the Human Environment
Baoming Liu, A. Wallace Hayes
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2401-2401
Open Access | Times Cited: 3
Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises
Natesh Singh, Bruno O. Villoutreix
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 2537-2548
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top